Johnson & Johnson (NYSE:JNJ) stands out in the list of 12 Reliable Dividend Stocks for Maximum Income.
Operating as a global leader in healthcare, Johnson & Johnson (NYSE:JNJ) specializes mainly in pharmaceuticals and medical devices. The company’s operations are categorized into two primary segments: Innovative Medicine, which focuses on the development and marketing of prescription medications, and MedTech, dedicated to the production of medical devices.
Until 2023, Johnson & Johnson (NYSE:JNJ) also had a successful consumer health division known for popular products such as Tylenol and Band-Aid. That segment has since been spun off into a separate company called Kenvue.
With a history that stretches over a century, Johnson & Johnson (NYSE:JNJ) has established a strong reputation for ongoing innovation and stability. The company has successfully managed to remain competitive in changing markets, navigate patent expirations, withstand economic downturns, and address global health emergencies.
On the financial front, Johnson & Johnson (NYSE:JNJ) continues to produce significant cash flows that support both reinvestment and returns to shareholders. In 2024 alone, the company is projected to allocate $17 billion towards research and development and distribute $11.8 billion in dividends, highlighting its strength as a dependable dividend-paying stock. It boasts a remarkable history, having increased its dividends for 63 consecutive years, with a current quarterly dividend amounting to $1.30 per share. As of October 13, the stock’s dividend yield stands at 2.72%.
While we recognize the appeal of JNJ as an investment opportunity, we believe that certain AI stocks may present greater potential for upside and reduced risk. If you’re interested in discovering an undervalued AI stock that is poised to gain significantly from tariffs enacted during the Trump administration and the trend of onshoring, check out our complimentary report on the best short-term AI stock.
READ NEXT: 12 Best Dividend Stocks With Yields Above 4% and Top 15 Dividend Growth Stocks for Long-Term Investors.
Disclosure: None.
